Zevra Therapeutics (ZVRA) Goodwill & Intangibles (2023 - 2026)

Zevra Therapeutics' Goodwill & Intangibles history runs 4 years deep, the most recent figure standing at $10.8 million for Q1 2026.

• Quarterly Goodwill & Intangibles fell 83.3% year-over-year to $10.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.8 million (down 83.3% YoY) and the FY2025 annual result came in at $11.1 million, down 84.91% from the prior year.
• Goodwill & Intangibles was $10.8 million for Q1 2026 at Zevra Therapeutics, down from $11.1 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $73.9 million in Q4 2023 and bottomed at $6.7 million in Q3 2024.
• A 4-year average of $34.2 million and a median of $11.6 million in 2025 frame the typical range for Goodwill & Intangibles.
• Peak annual rise in Goodwill & Intangibles reached 865.54% in 2025, while the deepest fall reached 84.91% in 2025.
• Zevra Therapeutics' Goodwill & Intangibles stood at $73.9 million in 2023, then fell by 0.32% to $73.7 million in 2024, then sank by 84.91% to $11.1 million in 2025, then slipped by 2.83% to $10.8 million in 2026.
• Business Quant data shows ZVRA's Goodwill & Intangibles at $10.8 million in Q1 2026, $11.1 million in Q4 2025, and $11.4 million in Q3 2025.